Integrated Analysis of Clinical and Microbiome Risk Factors Associated with the Development of Oral Candidiasis during Cancer Chemotherapy
Oral candidiasis is a common side effect of cancer chemotherapy. To better understand predisposing factors, we followed forty-five subjects who received 5-fluorouracil- or doxorubicin-based treatment, during one chemotherapy cycle. Subjects were evaluated at baseline, prior to the first infusion, an...
Main Authors: | Patricia I. Diaz, Bo-Young Hong, Amanda K. Dupuy, Linda Choquette, Angela Thompson, Andrew L. Salner, Peter K. Schauer, Upendra Hegde, Joseph A. Burleson, Linda D. Strausbaugh, Douglas E. Peterson, Anna Dongari-Bagtzoglou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | Journal of Fungi |
Subjects: | |
Online Access: | https://www.mdpi.com/2309-608X/5/2/49 |
Similar Items
-
Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis
by: Bo-Young Hong, et al.
Published: (2019-04-01) -
A prebiotic diet modulates the oral microbiome composition and results in the attenuation of oropharyngeal candidiasis in mice
by: Roberto Vazquez-Munoz, et al.
Published: (2023-10-01) -
Probiotics for Oral Candidiasis: Critical Appraisal of the Evidence and a Path Forward
by: Linda S. Archambault, et al.
Published: (2022-04-01) -
Anticandidal Activities by Lactobacillus Species: An Update on Mechanisms of Action
by: Roberto Vazquez-Munoz, et al.
Published: (2021-07-01) -
Candidiasis hepatoesplénica en un paciente con leucemia mieloide aguda Hepatosplenic candidiasis in acute myeloid leukemia
by: A. Larregina, et al.
Published: (2004-03-01)